PL376728A1 - Indole użyteczne do leczenia chorób związanych z receptorem androgenowym - Google Patents

Indole użyteczne do leczenia chorób związanych z receptorem androgenowym

Info

Publication number: PL376728A1
Authority: PL; Poland
Prior art keywords: alkyl; alkoxy; halogen; optionally substituted; androgen
Prior art date: 2002-11-07

Application number

PL376728A

Other languages

English (en)

Inventor

Pedro Harold Han Hermkens

Herman Thijs Stock

Neeltje Miranda Teerhuis

Johannes Patrus Maria Lommerse

Der Louw Jaap Van

Original Assignee

Akzo Nobel N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-07

Filing date

2003-11-03

Publication date

2006-01-09

2003-11-03 Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.

2006-01-09 Publication of PL376728A1 publication Critical patent/PL376728A1/pl

Links

102000001307 androgen receptors Human genes 0.000 title abstract 3
108010080146 androgen receptors Proteins 0.000 title abstract 3
238000011282 treatment Methods 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
150000002475 indoles Chemical class 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 13
229910052736 halogen Inorganic materials 0.000 abstract 6
125000003545 alkoxy group Chemical group 0.000 abstract 4
150000002367 halogens Chemical class 0.000 abstract 4
-1 2-nitrophenyl Chemical group 0.000 abstract 3
125000003709 fluoroalkyl group Chemical group 0.000 abstract 2
125000005843 halogen group Chemical group 0.000 abstract 2
125000000623 heterocyclic group Chemical group 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000002950 monocyclic group Chemical group 0.000 abstract 2
229920006395 saturated elastomer Polymers 0.000 abstract 2
125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 abstract 1
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
101100448208 Human herpesvirus 6B (strain Z29) U69 gene Proteins 0.000 abstract 1
102000007399 Nuclear hormone receptor Human genes 0.000 abstract 1
108020005497 Nuclear hormone receptor Proteins 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000005907 alkyl ester group Chemical group 0.000 abstract 1
125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000004428 fluoroalkoxy group Chemical group 0.000 abstract 1
CPRRHERYRRXBRZ-SRVKXCTJSA-N methyl n-[(2s)-1-[[(2s)-1-hydroxy-3-[(3s)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate Chemical compound COC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CO)C[C@@H]1CCNC1=O CPRRHERYRRXBRZ-SRVKXCTJSA-N 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000006574 non-aromatic ring group Chemical group 0.000 abstract 1
ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical compound CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000003637 steroidlike Effects 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Neurology (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)

PL376728A 2002-11-07 2003-11-03 Indole użyteczne do leczenia chorób związanych z receptorem androgenowym PL376728A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US42457902P	2002-11-07	2002-11-07
EP02079648		2002-11-07

Publications (1)

Publication Number	Publication Date
PL376728A1 true PL376728A1 (pl)	2006-01-09

Family

ID=42635437

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL376728A PL376728A1 (pl)	2002-11-07	2003-11-03	Indole użyteczne do leczenia chorób związanych z receptorem androgenowym

Country Status (15)

Country	Link
EP (1)	EP1585727B1 (pl)
JP (1)	JP4643989B2 (pl)
CN (1)	CN100391944C (pl)
AT (1)	ATE469128T1 (pl)
AU (1)	AU2003301853B2 (pl)
BR (1)	BR0316020A (pl)
CA (1)	CA2504907C (pl)
ES (1)	ES2344836T3 (pl)
NZ (1)	NZ539657A (pl)
PL (1)	PL376728A1 (pl)
RS (1)	RS20050340A (pl)
RU (1)	RU2328484C2 (pl)
TW (1)	TWI310032B (pl)
UA (1)	UA79504C2 (pl)
WO (1)	WO2004041782A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200602317A (en) *	2004-04-23	2006-01-16	Akzo Nobel Nv	Novel androgens
DE102004047272A1 (de) *	2004-09-24	2006-04-06	Schering Ag	Inhibitoren der löslichen Adenylatzyklase
DE102005027274A1 (de) *	2005-06-08	2006-12-14	Schering Ag	Inhibitoren der löslichen Adenylatzyklase
US7417066B2 (en)	2005-06-08	2008-08-26	Schering Ag	Inhibitors of soluble adenylate cyclase
CA2612723A1 (en) *	2005-06-24	2007-01-04	Eli Lilly And Company	Tetrahydrocarbazole derivatives useful as androgen receptor modulators
WO2007073231A1 (en) *	2005-12-23	2007-06-28	Victor Lvovoch Limonov	Agent for treating tumoral diseases, a method for the production thereof and a method for treating tumoral diseases
DE102006014324B4 (de)	2006-03-23	2009-01-08	Bayer Schering Pharma Aktiengesellschaft	Inhibitoren der löslichen Adenylatzyklase
SI2656842T1 (sl)	2006-03-27	2016-10-28	The Regents Of The University Of California	Modulator androgenih receptorjev za zdravljenje raka prostate in bolezni, povezanih z androgenimi receptorji
JP5275236B2 (ja) *	2006-09-29	2013-08-28	スミスクラインビーチャムコーポレーション	置換されたインドール化合物
CA2716320C (en)	2008-02-22	2014-01-28	Radius Health, Inc.	Selective androgen receptor modulators
US8268872B2 (en)	2008-02-22	2012-09-18	Radius Health, Inc.	Selective androgen receptor modulators
RU2408592C2 (ru) *	2008-12-31	2011-01-10	Федеральное государственное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" (ЮФУ)	Гидрогалогениды 3-[1-(2-гидрокси-3-пиперидин-1-ил-пропил)-1н-индол-3-ил]-1-фенил-пропенона, обладающие местноанестезирующей и антиаритмической активностью
AU2011212813B2 (en)	2010-02-04	2014-10-23	Radius Health, Inc.	Selective androgen receptor modulators
HUE030072T2 (en)	2010-05-12	2017-04-28	Radius Health Inc	Therapeutic prescriptions
US8642632B2 (en)	2010-07-02	2014-02-04	Radius Health, Inc.	Selective androgen receptor modulators
US9133182B2 (en)	2010-09-28	2015-09-15	Radius Health, Inc.	Selective androgen receptor modulators
NZ744456A (en)	2012-09-26	2019-09-27	Aragon Pharmaceuticals Inc	Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
ES3055185T3 (en)	2014-03-28	2026-02-10	Univ Duke	Treatment of an estrogen receptor positive breast cancer using a selective estrogen receptor modulator
US9421264B2 (en)	2014-03-28	2016-08-23	Duke University	Method of treating cancer using selective estrogen receptor modulators
MX389702B (es)	2016-06-22	2025-03-20	Ellipses Pharma Ltd	Compuestos para usarse en el tratamiento de cancer de mama que expresa el receptor de androgenos (ar+).
JP7481115B2 (ja)	2017-01-05	2024-05-10	ラジウスファーマシューティカルズ，インコーポレイテッド	Ｒａｄ１９０１－２ｈｃｌの多形性形態
CN113861186B (zh) *	2021-09-10	2023-08-25	浙江师范大学	基于异恶唑取代苯甲酰胺类衍生物及抗前列腺癌药物应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ179580A (en) *	1974-12-30	1978-04-03	Mcneilab Inc	2-or 3-(w-tertiaryaminoalkyl)-thioindoles and the corresponding sulfinyl and sulfonyl analogs
US4059583A (en) *	1975-11-13	1977-11-22	Mcneil Laboratories, Incorporated	Substituted indoles
GB9204365D0 (en) *	1992-02-28	1992-04-08	Pfizer Ltd	Indoles
RU2337909C2 (ru) *	2002-02-01	2008-11-10	Ф.Хоффманн-Ля Рош Аг	Замещенные индолы и фармацевтическая композиция, обладающая агонистической активностью в отношении альфа-1a/l адренорецептора
TW200401641A (en) *	2002-07-18	2004-02-01	Wyeth Corp	1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands

2003
- 2003-03-11 UA UAA200503773A patent/UA79504C2/uk unknown
- 2003-10-30 TW TW092130277A patent/TWI310032B/zh not_active IP Right Cessation
- 2003-11-03 BR BR0316020-3A patent/BR0316020A/pt not_active IP Right Cessation
- 2003-11-03 NZ NZ539657A patent/NZ539657A/en not_active IP Right Cessation
- 2003-11-03 JP JP2004549180A patent/JP4643989B2/ja not_active Expired - Fee Related
- 2003-11-03 CN CNB2003801039507A patent/CN100391944C/zh not_active Expired - Fee Related
- 2003-11-03 PL PL376728A patent/PL376728A1/pl not_active Application Discontinuation
- 2003-11-03 WO PCT/EP2003/050783 patent/WO2004041782A1/en not_active Ceased
- 2003-11-03 AT AT03810458T patent/ATE469128T1/de not_active IP Right Cessation
- 2003-11-03 ES ES03810458T patent/ES2344836T3/es not_active Expired - Lifetime
- 2003-11-03 CA CA2504907A patent/CA2504907C/en not_active Expired - Fee Related
- 2003-11-03 EP EP03810458A patent/EP1585727B1/en not_active Expired - Lifetime
- 2003-11-03 RU RU2005117374/04A patent/RU2328484C2/ru not_active IP Right Cessation
- 2003-11-03 AU AU2003301853A patent/AU2003301853B2/en not_active Ceased
- 2003-11-03 RS YUP-2005/0340A patent/RS20050340A/sr unknown

Also Published As

Publication number	Publication date
AU2003301853B2 (en)	2010-02-18
AU2003301853A1 (en)	2004-06-07
TW200418793A (en)	2004-10-01
JP4643989B2 (ja)	2011-03-02
UA79504C2 (en)	2007-06-25
WO2004041782A1 (en)	2004-05-21
TWI310032B (en)	2009-05-21
RS20050340A (sr)	2007-06-04
CN1714078A (zh)	2005-12-28
EP1585727A1 (en)	2005-10-19
JP2006507293A (ja)	2006-03-02
CA2504907C (en)	2011-10-11
ES2344836T3 (es)	2010-09-08
RU2328484C2 (ru)	2008-07-10
NZ539657A (en)	2008-04-30
ATE469128T1 (de)	2010-06-15
RU2005117374A (ru)	2006-01-20
EP1585727B1 (en)	2010-05-26
CA2504907A1 (en)	2004-05-21
CN100391944C (zh)	2008-06-04
BR0316020A (pt)	2005-09-20

Legal Events

Date	Code	Title	Description
2014-04-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
PL376728A1 (pl)	2006-01-09	Indole użyteczne do leczenia chorób związanych z receptorem androgenowym
BRPI0413233A (pt)	2006-10-03	novos compostos
ATE292628T1 (de)	2005-04-15	Chinazolinderivate
WO2007149448A3 (en)	2008-02-21	Pyrazinones as cellular proliferation inhibitors
DE60304059D1 (de)	2006-05-11	3-(2-hydroxy-phenyl)-1h-pyrazol-4-carbonsäureamid derivate als hsp90 inhibitoren zur behandlung von krebs
ATE449099T1 (de)	2009-12-15	Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
PE20061353A1 (es)	2006-12-29	Compuestos de sulfonamida-tiazolopiridina como activadores de glucocinasa
ES2191484T3 (es)	2003-09-01	Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
DE69823843D1 (de)	2004-06-17	Benzimidazolinone, benzoxazolinone, benzopiperazinone, indanone und deren derivate als faktor xa inhibitoren
WO2003106428A8 (fr)	2004-05-06	Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
DE60315615D1 (de)	2007-09-27	Tricyclische verbindungen auf thiophengrundlage und pharmazeutische zusammensetzungen, die diese enthalten
UA81561C2 (en)	2008-01-10	Use of n-arylhydrazine derivative and method for controlling non-crop pests
DE60014393D1 (de)	2004-11-04	Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
CO5261496A1 (es)	2003-03-31	Derivados de heterociclo-alquilsulfonil-pirazol como agentes antiinflamatorios/analgesicos
AR054021A1 (es)	2007-05-30	Derivados de ciclopentapiridina y tetrahidroquinolina
HUP0003942A2 (hu)	2001-04-28	Helyettesített 3,3-diamino-2-propén-nitrilek, előállításuk és alkalmazásuk
DK1202954T3 (da)	2004-02-09	Nye aminobenzophenoner
EA200602288A1 (ru)	2007-10-26	Замещённые тиазолуксусные кислоты в качестве лигандов crth2
TW200609218A (en)	2006-03-16	Bicyclic compounds
NO995935D0 (no)	1999-12-03	17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meiose
DK1163258T3 (da)	2003-03-31	Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis
ECSP055782A (es)	2005-08-11	Indoles útiles en el tratamiento de enfermedades relacionadas con el receptor de andrógeno
CO5160345A1 (es)	2002-05-30	Nuevos androgenos oralmente activos derivados de 7 alfa- metil-19-nortestosterona
NZ336969A (en)	2001-03-30	Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists
UA85512C2 (ru)	2009-01-26	Лиганды рецептора crth2 для применения в медицине